ロード中...
BCLC-B hepatocellular carcinoma treatment or when should the systemic therapy be started
Choice of the optimal therapy for BCLC-B hepatocellular carcinoma (HCC) is a significant clinical problem. Transarterial chemoembolisation (TACE) is considered to be the method of choice as this approach is reported to produce a direct effect and to have a significant survival rate. However, TACE is...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Russo |
| 出版事項: |
Remedium Group LLC
2018-07-01
|
| シリーズ: | Медицинский совет |
| 主題: | |
| オンライン･アクセス: | https://www.med-sovet.pro/jour/article/view/2529 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|